Analysts Are Updating Their Pulmonx Corporation (NASDAQ:LUNG) Estimates After Its Second-Quarter Results [Yahoo! Finance]
Pulmonx Corporation (LUNG)
US:NASDAQ Investor Relations:
investor.prolunginc.com/investor-relations
Company Research
Source: Yahoo! Finance
Pulmonx beat expectations with revenues of US$21m arriving 3.0% ahead of forecasts. The company also reported a statutory loss of US$0.39, 7.6% smaller than was expected. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. So we collected the latest post-earnings statutory consensus estimates to see what could be in store for next year. View our latest analysis for Pulmonx Taking into account the latest results, the consensus forecast from Pulmonx's six analysts is for revenues of US$82.7m in 2024. This reflects a credible 7.9% improvement in revenue compared to the last 12 months. Losses are expected to increase substantially, hitting US$1.65 per share. Yet prior to the latest earnings, the analysts had been forecasting revenues of US$82.6m and losses of US$1.67 per share in 2024. The consensus price target was unchange
Show less
Read more
Impact Snapshot
Event Time:
LUNG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LUNG alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LUNG alerts
High impacting Pulmonx Corporation news events
Weekly update
A roundup of the hottest topics
LUNG
News
- Pulmonx to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services ForumGlobeNewswire
- Pulmonx to Present at the Stifel 2024 Healthcare ConferenceGlobeNewswire
- Here's What Analysts Are Forecasting For Pulmonx Corporation (NASDAQ:LUNG) After Its Third-Quarter Results [Yahoo! Finance]Yahoo! Finance
- Pulmonx Third Quarter 2024 Earnings: EPS Beats Expectations [Yahoo! Finance]Yahoo! Finance
- Pulmonx Co. (NASDAQ: LUNG) had its price target lowered by analysts at Stifel Nicolaus from $17.00 to $16.00. They now have a "buy" rating on the stock.MarketBeat
LUNG
Earnings
- 10/30/24 - Beat
LUNG
Analyst Actions
- 10/31/24 - Stifel
LUNG
Sec Filings
- 11/8/24 - Form SC
- 11/1/24 - Form 10-Q
- 10/30/24 - Form 8-K
- LUNG's page on the SEC website